Allergy and Immunology, Allergy · Las Vegas, NV
NPI
1245284546
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4000 E Charleston Blvd Ste 100
Las Vegas, NV, 89104
Phone (702) 432-8250
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
17,112 services
Medicare patients, 2024
529
Average age 71
Drug cost, 2024
$3.3M
7,588 prescriptions
Company payments, 2025
$13K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Tottori was code 95004 (test - miscellaneous), 6,670 times for 113 patients. In total David H Tottori billed 17,112 services in 25 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 6,670 | 113 | $2.76 | $18K |
| 95165 Treatment - Miscellaneous | Office | 4,008 | 152 | $10.90 | $44K |
| 95117 Treatment - Miscellaneous | Office | 2,514 | 170 | $8.64 | $22K |
| 95044 Test - Miscellaneous | Office | 1,519 | 24 | $3.70 | $5,626 |
| 95024 Test - Miscellaneous | Office | 994 | 49 | $6.09 | $6,052 |
| 99213 Office E&M - Established | Office | 521 | 352 | $63.11 | $33K |
| 99204 Office E&M - New | Office | 152 | 152 | $116.52 | $18K |
| 96372 Injection Administration | Office | 151 | 22 | $9.27 | $1,400 |
| 94010 Pulmonary Function Testing | Office | 146 | 123 | $20.26 | $2,958 |
| 99212 Office E&M - Established | Office | 123 | 28 | $35.52 | $4,369 |
| 96160 E&M - Miscellaneous | Office | 55 | 35 | $1.93 | $106 |
| J2357 Injection, omalizumab, 5 mg | Office | 40 | 12 | $0.01 | $0.36 |
| 99203 Office E&M - New | Office | 21 | 21 | $80.93 | $1,699 |
By year: 2022 $149K for 14,377 services; 2023 $174K for 17,884 services; 2024 $159K for 17,112 services.
Medicare prescription drug claims, 2024
In 2024, the drug David H Tottori prescribed most often to Medicare patients was Montelukast Sodium, with 1,449 prescriptions and refills. In total David H Tottori wrote 7,588 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,449 | 2,614 | 433 | $9,497 |
| Fluticasone Propionate Generic | 1,183 | 1,901 | 485 | $13K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 751 | 888 | 275 | $22K |
| Azelastine Hcl Generic | 639 | 949 | 308 | $17K |
| Xolair Omalizumab | 356 | 357 | 43 | $1.1M |
| Epinephrine Generic | 321 | 380 | 237 | $62K |
| Ipratropium Bromide Generic | 285 | 406 | 128 | $7,600 |
| Triamcinolone Acetonide Generic | 251 | 324 | 138 | $2,355 |
| Breo Ellipta Fluticasone/Vilanterol | 221 | 269 | 51 | $104K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 216 | 360 | 63 | $37K |
| Dupixent Syringe Dupilumab | 159 | 168 | 22 | $650K |
| Famotidine Generic | 151 | 297 | 48 | $1,016 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 146 | 162 | 48 | $14K |
| Symbicort Budesonide/Formoterol Fumarate | 136 | 178 | 49 | $41K |
| Levocetirizine Dihydrochloride Generic | 129 | 258 | 39 | $886 |
Brand drugs: 2,501 claims; generic drugs: 5,087 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Tottori $13K ($13K in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $11K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 54 | $11K |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $277 |
| Genzyme Corporation SNY | 15 | $273 |
| Amgen Inc. AMGN | 8 | $149 |
| LEO Pharma Inc. | 5 | $104 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $94.99 |
| Medtronic, Inc. MDT | 1 | $81.03 |
| Arcutis Biotherapeutics, Inc. ARQT | 4 | $76.27 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 2 | $59.13 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $48.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.